OTC Markets OTCQX - Delayed Quote USD
Roche Holding AG (RHHVF)
318.68
+1.85
+(0.58%)
At close: April 24 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 1 | 18 | 18 |
Avg. Estimate | 15.34B | 15.95B | 63.93B | 66.74B |
Low Estimate | 15.23B | 15.95B | 60.74B | 63.72B |
High Estimate | 15.44B | 15.95B | 66.44B | 70.34B |
Year Ago Sales | 14.4B | 15.45B | 60.49B | 63.93B |
Sales Growth (year/est) | 6.54% | 3.24% | 5.68% | 4.40% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
RHHVF | -- | -- | -- | -- |
S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
NVSEF Novartis AG
111.41
0.00%
AZNCF AstraZeneca PLC
137.24
0.00%
NVSN.MX Novartis AG
2,235.00
0.00%
NONOF Novo Nordisk A/S
61.55
-3.15%
SNW.HA Sanofi SA
94.21
+0.87%
GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited
2,802.70
-3.89%
NOVN.SW Novartis AG
92.74
+0.80%
GRF.MC Grifols, S.A.
8.56
+1.30%
GSK GSK plc
37.50
+1.27%
BAYRY Bayer Aktiengesellschaft
6.43
-0.46%